Transforming Vision, Transforming Lives
Beacon Therapeutics (agtc.com) scores 80 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 74th percentile of 16300 Healthcare brands.
Beacon Therapeutics is a clinical-stage biotechnology company headquartered in Alachua, United States, that develops ophthalmic gene therapies. Its mission is to save and restore sight for people with rare and prevalent ocular diseases, including conditions such as X-Linked Retinitis Pigmentosa, Dry Age-related Macular Degeneration, and Cone Rod Dystrophy. The company positions itself as a pioneer in gene therapy aimed at addressing the underlying genetic causes of blinding eye diseases, targeting both patients and the broader medical and research community involved in ocular disease treatment.
| Brand Name | Beacon Therapeutics |
|---|---|
| Domain | agtc.com |
| Industry | Healthcare |
| Headquarters | Alachua, United States |
| Main Competitors | Adverum Biotechnologies (82/100), REGENXBIO (74/100), Spark Therapeutics (74/100), 4D Molecular Therapeutics (75/100), MeiraGTx (79/100), Editas Medicine (82/100) |
Moz Domain Authority 43/100 vs category average 40 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more." (Meta description: 17 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Breadcrumb/Website schema, og:title, og:description, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost.
Social footprint: verified profiles on X (Twitter), LinkedIn, Instagram, YouTube, GitHub; no detected presence on Facebook - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Beacon Therapeutics?", Claude could identify the brand as of October 2026. Beacon Therapeutics is a clinical-stage gene therapy company focused on treating inherited and acquired retinal diseases, formed in 2023 through a partnership between Syncona and the former AGTC (Applied Genetic Technologies Corporation), which is why the website still uses the a Best known for Developing gene therapies for retinal diseases like X-linked retinitis pigmentosa, building on AGTC's earlier gene therapy pipeline.
When asked "Best brands similar to Beacon Therapeutics?", Claude would recommend Beacon Therapeutics as of October 2026. It's a legitimate name in the ophthalmic gene therapy space worth mentioning alongside other retinal gene therapy developers.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Beacon Therapeutics's main competitors in Healthcare: Adverum Biotechnologies (82/100), REGENXBIO (74/100), Spark Therapeutics (74/100), 4D Molecular Therapeutics (75/100), MeiraGTx (79/100).
Sources: Brand Analyzer scan
Beacon Therapeutics has limited AI-search visibility, scoring 31/100 on Brand Analyzer's AI visibility composite (visibility 19, trust 37, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Beacon Therapeutics official site
Beacon Therapeutics scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Beacon Therapeutics official site
Beacon Therapeutics is a clinical-stage biotechnology company based in Alachua, United States, that develops gene therapies aimed at treating ophthalmic (eye) diseases.
Sources: Beacon Therapeutics official site
Beacon Therapeutics develops gene therapies designed to target the underlying genetic causes of blinding eye diseases, with the goal of restoring and preserving vision in patients with conditions such as X-Linked Retinitis Pigmentosa, Dry Age-related Macular Degeneration, and Cone Rod Dystrophy.
Sources: Beacon Therapeutics official site
Beacon Therapeutics can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Beacon Therapeutics official site
Beacon Therapeutics is known for its focus on ophthalmic gene therapy, specifically developing treatments intended to address rare and prevalent blinding eye diseases at the genetic level.
Sources: Beacon Therapeutics official site
Beacon Therapeutics' work is directed toward patients suffering from rare and prevalent blinding ocular diseases, such as X-Linked Retinitis Pigmentosa, Dry Age-related Macular Degeneration, and Cone Rod Dystrophy, as well as the medical and research community involved in diagnosing and treating these conditions.
Sources: Beacon Therapeutics official site
Beacon Therapeutics scores 31/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Beacon Therapeutics has a weak AI-visibility profile at 31/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (45/100) and its weakest is visibility (19/100). It benefits from a Wikidata knowledge-graph entry, a Moz Domain Authority of 43/100 and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Beacon Therapeutics from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Beacon Therapeutics: AGS Health (80/100), Age Management Medicine Group (AMMG) (80/100), Partnership for a Healthier America (80/100), European Air Ambulance (80/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.